Identifying similarities between metabolite alterations in GWS and ME/CFS is an important step toward uncovering potential therapeutic targets and enhancing our understanding of the underlying pathophysiology that contributes to shared symptoms, such as fatigue
However, there are a few key differences between the two types of solutions that must be taken into consideration when deciding which one to use
But if it does get approved, retatrutide is being studied as a weekly subcutaneous injection
While you cannot obtain GLP-1 directly from food, your dietary choices profoundly influence how much GLP-1 your own intestinal cells produce and release
Most side effects are not dangerous, but there are situations where you should seek medical advice
Therefore, DPP4i is particularly suitable for use in elderly, frail and/or vulnerable patients whose long-term type 2 diabetes and its complications often result in multidrug therapy